In March 1942, a 33-year-old woman lay dying of streptococcalsepsis in a New Haven, Connecticut, hospital, and despite thebest efforts of contemporary medical science, her doctors couldnot eradicate her bloodstream infection. Then they managed toobtain a small amount of a newly discovered substance calledpenicillin, which they cautiously injected into her. After repeateddoses, her bloodstream was cleared of streptococci, she madea full recovery, and she went on to live to the age of 90.1Sixty-six years after her startling recovery, a report2 describeda 70-year-old man in San Francisco with endocarditis causedby vancomycin-resistant . . . [Full Text of this Article]
Source Information
Dr. Arias is an assistant professor of medicine at the University of Texas Medical School, Houston, and director of the Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogotá, Colombia. Dr. Murray is a professor and the vice-chair for research in the Department of Internal Medicine and the director of the Division of Infectious Diseases, University of Texas Medical School, Houston.
This article has been cited by other articles:
Chen, Y.-H., Liu, C.-Y., Lu, J.-J., King, C.-H. R., Hsueh, P.-R.
(2009). In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. J Antimicrob Chemother
64: 1226-1229
[Abstract][Full Text]
Nakou, A., Woodhead, M., Torres, A.
(2009). MRSA as a cause of community-acquired pneumonia. Eur Respir J
34: 1013-1014
[Full Text]
Llarrull, L. I., Fisher, J. F., Mobashery, S.
(2009). Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New {beta}-Lactams That Meet the Challenge. Antimicrob. Agents Chemother.
53: 4051-4063
[Full Text]